The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Irisin inhibits hepatic gluconeogenesis and increases glycogen synthesis via the PI3K/Akt pathway in type 2 diabetic mice and hepatocytes
Abstract
Increased glucose production and reduced hepatic glycogen storage contribute to metabolic abnormalities in diabetes. Irisin, a newly identified myokine, induces the browning of white adipose tissue, but its effects on gluconeogenesis and glycogenesis are unknown. In the present study, we investigated the effects and underlying mechanisms of irisin on gluconeogenesis and glycogenesis in hepatocytes with insulin resistance, and its therapeutic role in type 2 diabetic mice. Insulin resistance was induced by glucosamine (GlcN) or palmitate in human hepatocellular carcinoma (HepG2) cells and mouse primary hepatocytes. Type 2 diabetes was induced by streptozotocin/high-fat diet (STZ/HFD) in mice. In HepG2 cells, irisin ameliorated the GlcN-induced increases in glucose production, phosphoenolpyruvate carboxykinase (PEPCK) and glucose-6-phosphatase (G6Pase) expression, and glycogen synthase (GS) phosphorylation; it prevented GlcN-induced decreases in glycogen content and the phosphoinositide 3-kinase (PI3K) p110α subunit level, and the phosphorylation of Akt/protein kinase B, forkhead box transcription factor O1 (FOXO1) and glycogen synthase kinase-3 (GSK3). These effects of irisin were abolished by the inhibition of PI3K or Akt. The effects of irisin were confirmed in mouse primary hepatocytes with GlcN-induced insulin resistance and in human HepG2 cells with palmitate-induced insulin resistance. In diabetic mice, persistent subcutaneous perfusion of irisin improved the insulin sensitivity, reduced fasting blood glucose, increased GSK3 and Akt phosphorylation, glycogen content and irisin level, and suppressed GS phosphorylation and PEPCK and G6Pase expression in the liver. Irisin improves glucose homoeostasis by reducing gluconeogenesis via PI3K/Akt/FOXO1-mediated PEPCK and G6Pase down-regulation and increasing glycogenesis via PI3K/Akt/GSK3-mediated GS activation. Irisin may be regarded as a novel therapeutic strategy for insulin resistance and type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A PGC1-α-dependent myokine that drives brown-fat-like development of white fat and thermogenesis
Boström, P., Wu, J., Jedrychowski, M. P., Korde, A., Ye, L., Lo, J. C., Rasbach, K. A., Boström, E. A., Choi, J. H., Long, J. Z., et al. (2012) · Nature · doi:10.1038/nature10777 · Cited by 4,810
Srinivasan, K., Viswanad, B., Asrat, L., Kaul, C. L., & Ramarao, P. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2005.05.004 · Cited by 1,874
Control of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Cohen, P., & Frame, S. (2001) · Nature Reviews Molecular Cell Biology · doi:10.1038/35096075 · Cited by 1,478
The role of hepatic lipids in hepatic insulin resistance and type 2 diabetes
Perry, R. J., Samuel, V. T., Petersen, K. F., & Shulman, G. I. (2014) · Nature · doi:10.1038/nature13478 · Cited by 1,136
Huh, J. Y., Panagiotou, G., Mougios, V., Brinkoetter, M., Vamvini, M. T., Schneider, B. E., & Mantzoros, C. S. (2012) · Metabolism · doi:10.1016/j.metabol.2012.09.002 · Cited by 1,040
A new rat model of type 2 diabetes: The fat-fed, streptozotocin-treated rat
Reed, M. J., Meszaros, K., Entes, L. J., Claypool, M. D., Pinkett, J. G., Gadbois, T. M., & Reaven, G. M. (2000) · Metabolism · doi:10.1053/meta.2000.17721 · Cited by 848
SIRT1 Improves Insulin Sensitivity under Insulin-Resistant Conditions by Repressing PTP1B
Sun, C., Zhang, F., Ge, X., Yan, T., Chen, X., Shi, X., & Zhai, Q. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.08.014 · Cited by 766
FROM MICE TO MEN: Insights into the Insulin Resistance Syndromes
Biddinger, S. B., & Kahn, C. R. (2006) · Annual Review of Physiology · doi:10.1146/annurev.physiol.68.040104.124723 · Cited by 706
Zhang, M., Lv, X.-Y., Li, J., Xu, Z.-G., & Chen, L. (2008) · Journal of Diabetes Research · doi:10.1155/2008/704045 · Cited by 667
Nakae, J., Biggs, W. H., Kitamura, T., Cavenee, W. K., Wright, C. V. E., Arden, K. C., & Accili, D. (2002) · Nature Genetics · doi:10.1038/ng890 · Cited by 616
REGULATION OF GLUCOSE PRODUCTION BY THE LIVER
Nordlie, R. C., Foster, J. D., & Lange, A. J. (1999) · Annual Review of Nutrition · doi:10.1146/annurev.nutr.19.1.379 · Cited by 585
Signalling through Class I PI3Ks in mammalian cells
Hawkins, P. T., Anderson, K. E., Davidson, K., & Stephens, L. R. (2006) · Biochemical Society Transactions · doi:10.1042/bst0340647 · Cited by 540
Novel concepts in insulin regulation of hepatic gluconeogenesis
Barthel, A., & Schmoll, D. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00253.2003 · Cited by 515
Lower circulating irisin is associated with type 2 diabetes mellitus
Liu, J.-J., Wong, M. D. S., Toy, W. C., Tan, C. S. H., Liu, S., Ng, X. W., Tavintharan, S., Sum, C. F., & Lim, S. C. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.03.002 · Cited by 446
Serum irisin levels in new-onset type 2 diabetes
Choi, Y.-K., Kim, M.-K., Bae, K. H., Seo, H.-A., Jeong, J.-Y., Lee, W.-K., Kim, J.-G., Lee, I.-K., & Park, K.-G. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.01.007 · Cited by 421
Stengel, A., Hofmann, T., Goebel-Stengel, M., Elbelt, U., Kobelt, P., & Klapp, B. F. (2013) · Peptides · doi:10.1016/j.peptides.2012.11.014 · Cited by 411
Kurdiova, T., Balaz, M., Vician, M., Maderova, D., Vlcek, M., Valkovic, L., Srbecky, M., Imrich, R., Kyselovicova, O., Belan, V., et al. (2014) · The Journal of Physiology · doi:10.1113/jphysiol.2013.264655 · Cited by 401
Favaro, E., Bensaad, K., Chong, M. G., Tennant, D. A., Ferguson, D. J. P., Snell, C., Steers, G., Turley, H., Li, J.-L., Günther, U. L., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.10.017 · Cited by 386
Irisin – a myth rather than an exercise-inducible myokine
Albrecht, E., Norheim, F., Thiede, B., Holen, T., Ohashi, T., Schering, L., Lee, S., Brenmoehl, J., Thomas, S., Drevon, C. A., et al. (2015) · Scientific Reports · doi:10.1038/srep08889 · Cited by 345
Gao, D., Nong, S., Huang, X., Lu, Y., Zhao, H., Lin, Y., Man, Y., Wang, S., Yang, J., & Li, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.128694 · Cited by 325
Lin, Y.-Y., Lu, J.-Y., Zhang, J., Walter, W., Dang, W., Wan, J., Tao, S.-C., Qian, J., Zhao, Y., Boeke, J. D., et al. (2009) · Cell · doi:10.1016/j.cell.2009.01.033 · Cited by 310
Mansuy-Aubert, V., Zhou, Q. L., Xie, X., Gong, Z., Huang, J.-Y., Khan, A. R., Aubert, G., Candelaria, K., Thomas, S., Shin, D.-J., et al. (2013) · Cell Metabolism · doi:10.1016/j.cmet.2013.03.005 · Cited by 245
The role of GSK3 in glucose homeostasis and the development of insulin resistance
Lee, J., & Kim, M.-S. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.01.033 · Cited by 245
FoxO1, the transcriptional chief of staff of energy metabolism
Kousteni, S. (2012) · Bone · doi:10.1016/j.bone.2011.06.034 · Cited by 238
Irisin is inversely associated with intrahepatic triglyceride contents in obese adults
Zhang, H.-J., Zhang, X.-F., Ma, Z.-M., Pan, L.-L., Chen, Z., Han, H.-W., Han, C.-K., Zhuang, X.-J., Lu, Y., Li, X.-J., et al. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.04.030 · Cited by 234
Targeting Forkhead Box O1 from the Concept to Metabolic Diseases: Lessons from Mouse Models
Cheng, Z., & White, M. F. (2011) · Antioxidants & Redox Signaling · doi:10.1089/ars.2010.3370 · Cited by 195
Basu, R., Chandramouli, V., Dicke, B., Landau, B., & Rizza, R. (2005) · Diabetes · doi:10.2337/diabetes.54.7.1942 · Cited by 189
Role of Glycogen Synthase Kinase-3 in Insulin Resistance and Type 2 Diabetes
Henriksen, E., & Dokken, B. (2006) · Current Drug Targets · doi:10.2174/1389450110607011435 · Cited by 185
Piya, M. K., Harte, A. L., Sivakumar, K., Tripathi, G., Voyias, P. D., James, S., Sabico, S., Al-Daghri, N. M., Saravanan, P., Barber, T. M., et al. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00308.2013 · Cited by 167
Aydin, S., Kuloglu, T., Aydin, S., Eren, M. N., Celik, A., Yilmaz, M., Kalayci, M., Sahin, İ., Gungor, O., Gurel, A., et al. (2014) · Peptides · doi:10.1016/j.peptides.2013.11.024 · Cited by 165
Targeting glycogen synthase kinase-3 (GSK-3) in the treatment of Type 2 diabetes
MacAulay, K., & Woodgett, J. R. (2008) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.12.10.1265 · Cited by 147
Miyamoto-Mikami, E., Sato, K., Kurihara, T., Hasegawa, N., Fujie, S., Fujita, S., Sanada, K., Hamaoka, T., Tabata, I., & Iemitsu, M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0120354 · Cited by 143
Irisin as a predictor of glucose metabolism in children: sexually dimorphic effects
Al‐Daghri, N. M., Alkharfy, K. M., Rahman, S., Amer, O. E., Vinodson, B., Sabico, S., Piya, M. K., Harte, A. L., McTernan, P. G., Alokail, M. S., et al. (2013) · European Journal of Clinical Investigation · doi:10.1111/eci.12196 · Cited by 111
Lower irisin level in patients with type 2 diabetes mellitus: A case‐control study and meta‐analysis
Zhang, C., Ding, Z., Lv, G., Li, J., Zhou, P., & Zhang, J. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12256 · Cited by 98
Irisin in obesity and type 2 diabetes
Højlund, K., & Boström, P. (2013) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2013.04.002 · Cited by 76
Reduction of Hepatic Glucose Production as a Therapeutic Target in the Treatment of Diabetes
Wu, C., Okar, D. A., Kang, J., et al. (2005) · Current Drug Targets - Immune Endocrine & Metabolic Disorders · doi:10.2174/1568008053174769 · Cited by 72
Gluconeogenesis and Glycogenolysis in Health and Diabetes
Boden, G. H. (2004) · Journal of Investigative Medicine · doi:10.1136/jim-52-06-31 · Cited by 54
Aydın, S., Ögetürk, M., Kuloğlu, T., Kavaklı, A., & Aydın, S. (2014) · Peptides · doi:10.1016/j.peptides.2014.11.008 · Cited by 44
Wang, Q., Wang, N., Dong, M., Chen, F., Li, J. Z., & Chen, Y. (2014) · Clinical Science · doi:10.1042/cs20130670 · Cited by 28
Pérez-Mendoza, M., Rivera-Zavala, J. B., & Díaz‐Muñoz, M. (2014) · Chronobiology International · doi:10.3109/07420528.2014.908898 · Cited by 28
Tsintzas, K., Norton, L., Chokkalingam, K., Nizamani, N., Cooper, S., Stephens, F. B., Billeter-Clark, R., & Bennett, A. J. (2013) · Clinical Science · doi:10.1042/cs20120481 · Cited by 26
Maternal inheritance of circulating irisin in humans
Al‐Daghri, N. M., Al-Attas, O. S., Alokail, M. S., Alkharfy, K. M., Yousef, M., Vinodson, B., Amer, O. E., Alnaami, A. M., Sabico, S., Tripathi, G., et al. (2014) · Clinical Science · doi:10.1042/cs20130426 · Cited by 17
Cited by
The PI3K/AKT Pathway in Obesity and Type 2 Diabetes
Huang, X., Liu, G., Guo, J., & Su, Z. (2018) · International Journal of Biological Sciences · doi:10.7150/ijbs.27173 · Cited by 1,673
Physiology and role of irisin in glucose homeostasis
Perakakis, N., Triantafyllou, G. A., Fernández-Real, J. M., Huh, J. Y., Park, K. H., Seufert, J., & Mantzoros, C. S. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.221 · Cited by 621
Zhang, X., Hu, C., Kong, C.-Y., Song, P., Wu, H.-M., Xu, S.-C., Yuan, Y.-P., Deng, W., Ma, Z.-G., & Tang, Q.-Z. (2020) · Cell Death & Differentiation · doi:10.1038/s41418-019-0372-z · Cited by 442
PGC-1α as a Pivotal Factor in Lipid and Metabolic Regulation
Cheng, C.-F., Ku, H.-C., & Lin, H. (2018) · International Journal of Molecular Sciences · doi:10.3390/ijms19113447 · Cited by 437
Cell-cell communication: New insights and clinical implications
Su, J., Song, Y., Zhu, Z., Huang, X., Fan, J., Qiao, J., & Mao, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01888-z · Cited by 433
Metadata
- Authors
- Liu, T.-Y., Shi, C.-X., Gao, R., Sun, H.-J., Xiong, X.-Q., Ding, L., Chen, Q., Li, Y.-H., Wang, J.-J., Kang, Y.-M., & Zhu, G.-Q.
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2015-08-19
- Volume
- 129
- Issue
- 10
- Pages
- 839-850
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W1962787573
- Cited by
- 370
- References
- 43
- FWCI
- 8.11
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.